Grufity logoGrufity logo

SYK

243.11USD+2.34(+0.97%)Market Closed

Stryker Corp

Market Summary

USD243.11+2.34Market Closed
0.97%

SYK Alerts

SYK Stock Price

RSI Chart

Valuation

Market Cap

86.7B

Price/Earnings

41.71

Price/Sales

4.92

Price/Cashflow

32.54

MarketCap/EBT

36.78

Price/Sales

Profitability

Operating Margin

63.80%

EBT Margin

13.38%

Return on Equity

13.26%

Return on Assets

5.77%

Fundamentals

Revenue

Revenue (TTM)

17.9B

Revenue Y/Y

7.67%

Revenue Q/Q

-0.31%

Earnings

Earnings (TTM)

2.5B

Earnings Y/Y

86.3%

Earnings Q/Q

24.39%

Price Action

52 Week Range

278.73
(Low)(High)

Last 7 days

4.5%

Last 30 days

14.7%

Last 90 days

19.3%

Trailing 12 Months

-0.9%

Financial Health

Current Ratio

2

Investor Care

Dividend Yield

1.17%

Dividend/Share (TTM)

2.78

Shares Dilution (1Y)

0.37%

Diluted EPS (TTM)

6.43

Peers (Alternatives to Stryker)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
10.2T
429.9M
-11.88% 44.84%
185.5K
28.0K
144.70% 331.94%
86.7B
17.9B
14.69% -0.88%
41.71
4.92
7.67% 29.32%
86.3B
6.1B
15.30% -16.82%
62.6
14.1
11.47% -18.42%
67.1B
18.9B
10.69% 8.01%
38.21
3.25
-6.81% -14.96%
61.8B
12.3B
11.14% 17.68%
69.9
5.01
10.11% 51.89%
43.9B
5.4B
8.87% -30.30%
30.09
8.18
5.29% -1.25%
MID-CAP
6.7B
998.4M
15.24% 17.79%
44.21
6.87
6.04% -19.01%
6.4B
806.4M
33.98% -14.84%
-331.15
7.96
20.10% -221.96%
3.9B
380.1M
-8.48% 5.83%
-29.57
10.69
18.85% -63.58%
3.6B
790.7M
-16.73% -66.49%
-273.58
4.7
19.65% -412.22%
SMALL-CAP
1.6B
126.8M
26.44% 24.39%
-26.38
14.01
34.44% -10.05%
1.1B
291.9M
9.49% -7.06%
-6.57
3.67
52.45% -57.74%
1.0B
795.9M
17.05% -10.97%
-131.34
1.33
8.11% 182.50%
606.7M
236.2M
-6.64% -29.40%
-16.43
2.57
-8.79% -175.19%

Financials for Stryker

Income Statement (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Revenue1.8%17,94817,62917,43017,10816,669
Gross Profit1.2%11,38711,24711,19310,96810,640
Operating Expenses-1.1%8,5418,6358,6218,3848,126
  S&GA Expenses-2.2%6,4496,5966,5626,4276,244
  R&D Expenses4.1%1,4591,4011,3601,2351,159
Earnings Before Taxes13.6%2,6792,3582,3002,2812,195
Net Income18.2%2,4572,0792,0151,9941,900
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Assets-0.1%35,98336,03236,13734,63134,145
  Current Assets5.6%9,3188,8258,72510,0179,460
    Cash Equivalents36.0%1,4201,0441,4582,9442,563
  Inventory3.6%3,8833,7493,5253,3143,434
  Net PPE-0.2%2,7982,8032,7932,8332,746
  Goodwill-0.8%14,99315,11515,22812,91812,893
Liabilities-4.1%19,52020,35821,09119,75419,967
  Current Liabilities3.8%4,5714,4044,4084,5494,449
    LT Debt, Non Current-4.7%12,75113,37413,88512,47212,629
Shareholder's Equity5.0%16,46315,67415,04614,87714,178
  Retained Earnings4.0%14,48613,93313,54013,48013,081
  Additional Paid-In Capital2.2%1,9891,9471,8901,875-
Accumulated Depreciation-0.4%2,7362,7462,7392,6652,694
Shares Outstanding0.2%378378377--
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Cashflow From Operations-1.7%2,6212,6653,0143,2633,500
  Share Based Compensation-0.6%170171174171168
Cashflow From Investing9.4%-3,076.00-3,395.00-3,445.00-859.00-4,897.00
Cashflow From Financing-49.2%-591.00-396.00-319.00-2,365.00-3,134.00
  Dividend Payments2.5%1,0251,000974950929
  Buy Backs-0
* denotes actual numbers (not divided by Millions)

Risks

What is the probability of a big loss on SYK?

29.6%


Probability that Stryker stock will be more than 20% underwater in next one year

18.5%


Probability that Stryker stock will be more than 30% underwater in next one year.

0%


Probability that Stryker stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does SYK drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Stryker was unfortunately bought at previous high price.

Returns

Cumulative Returns on SYK

17.7%


10-Year Cumulative Returns

15.8%


7-Year Cumulative Returns

10.5%


5-Year Cumulative Returns

7.3%


3-Year Cumulative Returns

What are the long-term rolling returns for SYK?

FIve years rolling returns for Stryker.

Which funds bought or sold SYK recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2022-11-29
SALEM CAPITAL MANAGEMENT INC
-
-
4,000
246,000
0.20%
2022-11-23
Eagle Bay Advisors LLC
REDUCED
-40
-3,941
7,000
-%
2022-11-23
Invst, LLC
ADDED
80.04
144,000
347,000
0.06%
2022-11-23
Toroso Investments, LLC
ADDED
14.03
241,000
1,738,000
0.07%
2022-11-22
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
NEW
-
6,485,000
6,485,000
0.08%
2022-11-22
CONTINENTAL INVESTORS SERVICES, INC.
NEW
-
12,117,000
12,117,000
0.45%
2022-11-22
B. Riley Wealth Advisors, Inc.
ADDED
33.88
1,538,000
5,775,000
0.17%
2022-11-22
CVA Family Office, LLC
-
-
52,000
211,000
0.06%
2022-11-22
IHT Wealth Management, LLC
-
-
91,000
316,000
0.02%
2022-11-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
-
-
888,000
116,892,000
0.20%

1–10 of 46

Latest Funds Activity

Are funds buying SYK calls or puts?
Are funds bullish or bearish(Calls - Puts)?
No. of funds that own SYK

Stryker News

MarketWatch

Zimmer Biomet Holdings Inc. stock falls Friday, underperforms market.28 hours ago

SYK Fair Value

Recent SEC filings of Stryker

View All Filings
Date Filed Form Type Document
Nov 18, 2022
4
Insider Trading
Nov 15, 2022
8-K
Current Report
Nov 08, 2022
4
Insider Trading
Nov 04, 2022
4
Insider Trading
Nov 03, 2022
4
Insider Trading
Nov 02, 2022
4
Insider Trading
Nov 01, 2022
IRANNOTICE
IRANNOTICE
Nov 01, 2022
10-Q
Quarterly Report
Oct 31, 2022
8-K
Current Report
Oct 04, 2022
4
Insider Trading

Latest Insider Trading transactions for SYK

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2022-11-16
Becker Yin C
SOLD FOR TAXES
-649,928
221.97
-2,928
VP, Chief Corp Affairs Officer
2022-11-16
Becker Yin C
ACQUIRED
312,689
64.01
4,885
VP, Chief Corp Affairs Officer
2022-11-07
Datar Srikant M.
SOLD
-63,707.2
212.357
-300
-
2022-11-02
Fink M Kathryn
SOLD
-74,691.2
219.68
-340
VP, Chief HR Officer
2022-11-02
Datar Srikant M.
SOLD
-130,026
216.71
-600
-
2022-11-01
Stiles Spencer S
SOLD FOR TAXES
-164,365
229.24
-717
Group President
2022-08-01
Pierce James Andrew
SOLD (Taxes)
-81,605
214.75
-380
Group President
2022-08-01
Stiles Spencer S
ACQUIRED
-
-
765
Group President
2022-08-01
Stiles Spencer S
SOLD (Taxes)
-71,726.5
214.75
-334
Group President
2022-08-01
Pierce James Andrew
ACQUIRED
-
-
765
Group President

1–10 of 50

Kevin A. Lobo
46000
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

SYK Income Statement

2022-09-30
CONSOLIDATED STATEMENTS OF EARNINGS (Unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]    
Net sales$ 4,479$ 4,160$ 13,247$ 12,407
Cost of sales1,6971,5184,9054,484
Gross profit2,7822,6428,3427,923
Research, development and engineering expenses3643061,128904
Selling, general and administrative expenses1,4551,6024,7044,682
Recall charges(4)161498
Amortization of intangible assets159144469474
Total operating expenses1,9742,0686,3156,158
Operating income8085742,0271,765
Other income (expense), net8(79)(105)(241)
Earnings before income taxes8164951,9221,524
Income taxes057127192
Net earnings$ 816$ 438$ 1,795$ 1,332
Net earnings per share of common stock:    
Basic$ 2.16$ 1.17$ 4.75$ 3.54
Diluted$ 2.14$ 1.14$ 4.70$ 3.48
Weighted-average shares outstanding (in millions):    
Basic378.4377.1378.1376.8
Effect of dilutive employee stock compensation3.45.64.15.5
Diluted381.8382.7382.2382.3
Cash dividends declared per share of common stock (in dollars per share)$ 0.695$ 0.63$ 2.085$ 1.89

SYK Balance Sheet

2022-09-30
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Current assets  
Cash and cash equivalents$ 1,420$ 2,944
Marketable securities7775
Accounts receivable, less allowance of $150 ($167 in 2021)3,1033,022
Inventories:  
Materials and supplies852691
Work in process309264
Finished goods2,7222,359
Total inventories3,8833,314
Prepaid expenses and other current assets835662
Total current assets9,31810,017
Property, plant and equipment:  
Land, buildings and improvements1,6651,656
Machinery and equipment3,8693,842
Total property, plant and equipment5,5345,498
Less accumulated depreciation2,7362,665
Property, plant and equipment, net2,7982,833
Goodwill14,99312,918
Other intangibles, net5,0534,840
Noncurrent deferred income tax assets1,3901,760
Other noncurrent assets2,4312,263
Total assets35,98334,631
Current liabilities  
Accounts payable1,2131,129
Accrued compensation9271,092
Income taxes243192
Dividends payable263263
Accrued product liabilities391401
Accrued expenses and other liabilities1,5261,465
Current maturities of debt87
Total current liabilities4,5714,549
Long-term debt, excluding current maturities12,75112,472
Income taxes621913
Other noncurrent liabilities1,5771,820
Total liabilities19,52019,754
Shareholders' equity  
Common stock, $0.10 par value3838
Additional paid-in capital2,0281,890
Retained earnings14,48613,480
Accumulated other comprehensive loss(89)(531)
Total shareholders' equity16,46314,877
Total liabilities and shareholders' equity$ 35,983$ 34,631
Common stock, par value (in dollars per share)$ 0.10$ 0.10